Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) announced the initiation of polymer process development and analytical characterization activities by Nanosoft Polymers in support of ONC010, the company's lead nanoparticle-formulated Polynucleotide Kinase Phosphatase (PNKP) inhibitor. This collaboration marks a critical step in advancing the chemistry, manufacturing and controls (CMC) strategy for the drug candidate, which targets solid tumors.
The work includes polymer synthesis optimization, characterization methodology development, molecular weight assessment, purification strategy refinement and manufacturing scalability assessments. These activities are intended to establish a scalable, reproducible and analytically characterized polymer platform to support future formulation, manufacturing, regulatory and clinical development. By leveraging Nanosoft's expertise in polymer science and nanoparticle drug delivery, Onco-Innovations expects to strengthen the technical foundation of the ONC010 platform while supporting future Good Manufacturing Practice (GMP) manufacturing readiness.
Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. The company's mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. It has secured an exclusive worldwide license to patented technology that targets solid tumors. The advancement of ONC010 represents a significant milestone in the company's pipeline, potentially offering a novel therapeutic approach for cancer patients.
Nanosoft Polymers is a specialized polymer chemistry company with deep expertise in designing and manufacturing advanced polymers for drug delivery applications. Their involvement is expected to accelerate the development of a robust manufacturing process for ONC010, addressing key challenges in nanoparticle formulation consistency and scalability.
For more details, the full press release is available at https://nnw.fm/BeSoS. The latest news and updates regarding ONNVF can be found in the company's newsroom at https://nnw.fm/ONNVF.
